Improved experimental time of ultra-large bioassays using a parallelised microfluidic biochip architecture/scheduling

Area of Science:

• Biotechnology
• Microfluidics
• Biochemistry

Background:

• Digital microfluidics offers reduced cost, time, and improved flexibility for biochemical assays.
• Large-scale bio-operations in drug discovery and DNA profiling necessitate parallel processing for accuracy and cost-efficiency.
• Digital microfluidic biochips are a promising platform for parallelizing complex bioassays.

Purpose of the Study:

• To introduce a novel microfluidic architecture for parallelizing bioassays.
• To develop a corresponding Computer-Aided Design (CAD) flow to support the new architecture.
• To enhance the efficiency and throughput of digital microfluidic biochips.

Main Methods:

• Implementation of a proposed digital microfluidic architecture.
• Evaluation of the architecture using large-scale, real-world bioassays.
• Simulation to quantify improvements in parallelism and speed.

Main Results:

• The new architecture demonstrated a significant increase in the degree-of-parallelism for bioassays.
• Assay speeds were enhanced by more than 4× compared to existing methods.
• Simulations indicate greater improvements for larger and more complex bioassays.

Conclusions:

• The developed microfluidic architecture effectively parallelizes bioassays on digital microfluidic platforms.
• This advancement significantly boosts assay speed and throughput, with potential for further gains in larger applications.
• The contribution holds promise for accelerating drug testing, biological experiments, and medical diagnostics involving time-consuming procedures.